1. Home
  2. RLYB vs OPXS Comparison

RLYB vs OPXS Comparison

Compare RLYB & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLYB
  • OPXS
  • Stock Information
  • Founded
  • RLYB 2018
  • OPXS 1987
  • Country
  • RLYB United States
  • OPXS United States
  • Employees
  • RLYB N/A
  • OPXS N/A
  • Industry
  • RLYB Biotechnology: Pharmaceutical Preparations
  • OPXS Electronic Components
  • Sector
  • RLYB Health Care
  • OPXS Technology
  • Exchange
  • RLYB Nasdaq
  • OPXS Nasdaq
  • Market Cap
  • RLYB 46.1M
  • OPXS 54.2M
  • IPO Year
  • RLYB 2021
  • OPXS N/A
  • Fundamental
  • Price
  • RLYB $1.10
  • OPXS $8.42
  • Analyst Decision
  • RLYB Buy
  • OPXS
  • Analyst Count
  • RLYB 6
  • OPXS 0
  • Target Price
  • RLYB $8.30
  • OPXS N/A
  • AVG Volume (30 Days)
  • RLYB 50.8K
  • OPXS 19.5K
  • Earning Date
  • RLYB 11-07-2024
  • OPXS 11-12-2024
  • Dividend Yield
  • RLYB N/A
  • OPXS N/A
  • EPS Growth
  • RLYB N/A
  • OPXS 132.50
  • EPS
  • RLYB N/A
  • OPXS 0.61
  • Revenue
  • RLYB $299,000.00
  • OPXS $32,628,999.00
  • Revenue This Year
  • RLYB N/A
  • OPXS N/A
  • Revenue Next Year
  • RLYB N/A
  • OPXS N/A
  • P/E Ratio
  • RLYB N/A
  • OPXS $13.85
  • Revenue Growth
  • RLYB N/A
  • OPXS 34.17
  • 52 Week Low
  • RLYB $1.08
  • OPXS $3.75
  • 52 Week High
  • RLYB $4.60
  • OPXS $8.99
  • Technical
  • Relative Strength Index (RSI)
  • RLYB 45.64
  • OPXS 63.68
  • Support Level
  • RLYB $1.09
  • OPXS $7.78
  • Resistance Level
  • RLYB $1.18
  • OPXS $8.46
  • Average True Range (ATR)
  • RLYB 0.04
  • OPXS 0.28
  • MACD
  • RLYB 0.00
  • OPXS 0.08
  • Stochastic Oscillator
  • RLYB 11.11
  • OPXS 95.41

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Richardson and Applied Optics Center Dallas. It generates maximum revenue from the Applied Optics Center Dallas segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.

Share on Social Networks: